证据资料库

阅读肽市场报告

市场报告使用不同定义、时间范围和估算方法。比较数字前请先比较这些假设。

所引企业、机构与数据仅提供公开行业背景,不代表与本公司的合作、背书、认证或商业关系。

来源涵盖内容

市场报告使用不同定义、时间范围和估算方法。比较数字前请先比较这些假设。

明确范围

这些独立来源不证明与 BLOPEP 存在合作关系,也不证明我们的产品获得认证或某批次获批。详情与局限请查阅原始文件。

来源与核实范围

商业估算 · S01

Peptide Therapeutics Market Report 2026 ↗

The Business Research Company

来源详情(原文语言)
范围
Publisher estimate of peptide therapeutics, 2025–2030
文件位置
Market overview; market size and growth forecast
局限
Not a research-material market or company revenue. Segmentation and CAGR inconsistencies were not imported.
陈述核实日期
2026-09-09
科学文献 · S02

Advance in peptide-based drug development: delivery platforms, therapeutics and vaccines ↗

Xiao et al. · Signal Transduction and Targeted Therapy

来源详情(原文语言)
范围
Historical review reporting 28 approvals in 2014–2024 and 38 phase III candidates
文件位置
Peptide-based drug market & clinical trial; Figure 4 and Tables 2–3
局限
Denominators differ between narrative and tables; no new percentages or current regulatory count inferred.
陈述核实日期
2026-09-09
科学文献 · S04

Therapeutic peptides: current applications and future directions ↗

Wang et al. · Signal Transduction and Targeted Therapy

来源详情(原文语言)
范围
Review of therapeutic peptide development
文件位置
Introduction; production, modification and applications
局限
Historical review, not validation of products or batches. More than 80 approved drugs is a 2022 literature statement.
陈述核实日期
2026-09-09